Article Information
History
- September 23, 2020.
Article Versions
- Version 1 (May 23, 2020 - 22:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ladan Goshayeshi1,2,†,
- Mina Akbari Rad3,†,
- Robert Bergquist4,
- Abolghasem Allahyari3,
- members of the MUMS Covid-19 Research Team5 and
- Benyamin Hoseini6,7,*
- 1Department of Gastroenterology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- 2Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
- 3Department of internal medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- 4Ingerod, SE-454 94 Brastad, Sweden; Formerly UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland
- 5A full list of the research team members is provided in Supplementary Note online
- 6Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
- 7Department of Health Information Technology, Neyshabur University of Medical Sciences, Neyshabur, Iran
- ↵*Corresponding author: Benyamin Hoseini
, Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Health Information Technology, Neyshabur University of Medical Sciences, Neyshabur, Iran; Tel: +985143306219, Cellphone: +989127858864; Email: Hoseinib1{at}nums.ac.ir.
↵† Ladan Goshayeshi and Mina Akbari Rad contributed equally as joint lead authors.
Posted September 23, 2020.
Demographic and Clinical Characteristics of the Severe Covid-19 Infections: First Report from Mashhad University of Medical Sciences, Iran
